Reflecting on a scary road rage incident reminds columnist Kristin Neva of the fragility of life. None of us is guaranteed tomorrow.

Columnist Dagmar Munn shares how she finds ways to keep her anxiety and ALS fears in check with a few simple responses.

Klotho is advancing its ALS gene therapy candidate KLTO‑202 to the manufacturing phase, and is planning the first human ...

KLTO-202 designed to slow disease progression KLTO-202 is designed to boost the production of that protein in muscle and nerve cells by delivering the gene that codes for s-KL via a modified and ...

The FDA granted orphan drug designation to Sineugene Therapeutics' SNUG01, a first-in-class experimental gene therapy for ...